Veraxa Biotech Holding AG (VRXA) Total Liabilities (2024 - 2025)
Veraxa Biotech Holding AG's (VRXA) quarterly Total Liabilities came in at $120.8 million in Q4 2025, up 97.1% year-on-year from $61.3 million in Q4 2024, and up 97.1% on a QoQ basis from $61.3 million in Q4 2024.
Veraxa Biotech Holding AG (VRXA) Total Liabilities (2024 - 2025) Analysis & Trends
Veraxa Biotech Holding AG (VRXA) has 2 years of Total Liabilities data on file, last reported at $120.8 million in Q4 2025.
- On a quarterly basis, Total Liabilities rose 97.1% year-over-year to $120.8 million in Q4 2025; TTM through Dec 2025 was $120.8 million, a 97.1% increase from a year earlier, with the FY2025 full-year figure at $120.8 million, up 97.1% from the prior year.
- Total Liabilities for Q4 2025 stood at $120.8 million, up from $61.3 million in the prior quarter.
- Over the last five years, Total Liabilities for VRXA reached as high as $120.8 million in Q4 2025 and fell as low as $61.3 million in Q4 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 120.85 Mn |
| Dec 31, 2024 | 61.31 Mn |